M, G., S, C., H, D., M, C., & H, C. (2026). Musculoskeletal adverse events with incretin-based diabetes drugs: A FAERS pharmacovigilance study. Naunyn-Schmiedeberg's archives of pharmacology, 399(8), 11975. https://doi.org/10.1007/s00210-026-05113-2
Chicago Style (17th ed.) CitationM, Guo, Chen S, Dong H, Cai M, and Cheng H. "Musculoskeletal Adverse Events with Incretin-based Diabetes Drugs: A FAERS Pharmacovigilance Study." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 8 (2026): 11975. https://doi.org/10.1007/s00210-026-05113-2.
MLA (9th ed.) CitationM, Guo, et al. "Musculoskeletal Adverse Events with Incretin-based Diabetes Drugs: A FAERS Pharmacovigilance Study." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 8, 2026, p. 11975, https://doi.org/10.1007/s00210-026-05113-2.